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Background: The mechanisms behind Aβ-peptide accumulation in non-familial Alzheimer’s disease (AD) remain
elusive. Proteins of the tetraspanin family modulate Aβ production by interacting to γ-secretase.
Methods: We searched for tetraspanins with altered expression in AD brains. The function of the selected tetraspanin
was studied in vitro and the physiological relevance of our findings was confirmed in vivo.
Results: Tetraspanin-6 (TSPAN6) is increased in AD brains and overexpression in cells exerts paradoxical effects on
Amyloid Precursor Protein (APP) metabolism, increasing APP-C-terminal fragments (APP-CTF) and Aβ levels at the same
time. TSPAN6 affects autophagosome-lysosomal fusion slowing down the degradation of APP-CTF. TSPAN6 recruits
also the cytosolic, exosome-forming adaptor syntenin which increases secretion of exosomes that contain APP-CTF.
Conclusions: TSPAN6 is a key player in the bifurcation between lysosomal-dependent degradation and exosome
mediated secretion of APP-CTF. This corroborates the central role of the autophagosomal/lysosomal pathway in APP
metabolism and shows that TSPAN6 is a crucial player in APP-CTF turnover.
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Alzheimer’s disease (AD) is a devastating neurodegenera-
tive disease and the first cause of human dementia [1].
Quantitative and qualitative alterations of the amyloid
Aβ peptides together with tau-pathology, initiate a long
cycle of cellular action and reaction eventually leading to
severe neuronal loss [2]. Aβ peptides are generated from
the transmembrane protein Amyloid Precursor Protein
(APP) by proteolytic activities exerted by the β-secretase
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nents of the γ-secretases complexes) alter Aβ production
in familial AD cases [4], the mechanisms by which Aβ-
peptide production, clearance and aggregation are altered
in non-familial cases is of varied etiology [5–11].
Detergent resistant membrane (DRM) and tetraspanin-
enriched microdomains (TEMs) play important roles in
the regulation of the proteases that generate Aβ [12–17].
TEMs represent molecular assemblies of proteins and
lipids based on multiple interactions involving four-
transmembrane-domain proteins of the tetraspanin
superfamily [18, 19]. In an unbiased proteomic analysis,
our laboratory found that tetraspanins CD9 and CD81
(also known as TSPAN28 and TSPAN29) interact with
components of the γ-secretase complex and modulate
its activity towards APP [20]. Two other tetraspaninsle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Tetraspanins also play a role in the maturation and
trafficking of ADAM10, one of the enzymes involved in
the non-amyloidogenic cleavage of APP [22–24] and
finally, interact with the γ-secretase complexes and
ADAM10 or BACE1 to form supramolecular complexes
in the membrane [17]. Beyond their involvement in the
regulation of these proteolytic enzymes, tetraspanins
play a crucial role in many other cellular processes,
from the control of the endocytic trafficking to
autophagic-induced cell death [18, 25–28]. Specifically,
our interest in the role of tetraspanin-6 (TSPAN6) in
sporadic AD was supported by observations from sev-
eral independent groups which indicate that the mRNA
levels of TSPAN6 are increased in the prefrontal cortex
of AD patients and correlate with Braak stage progres-
sion [29–31]. Therefore, we decided to focus our stud-
ies on the role that TSPAN6 plays in the molecular
pathogenesis of sporadic AD.
We demonstrate here that overexpression of TSPAN6
affects APP metabolism, but unexpectedly, this effect
does not involve the γ-secretases. In contrast, we deter-
mined that TSPAN6 is enriched in multivesicular bodies
(MVBs) and intraluminal vesicles (ILVs). Increasing
TSPAN6 levels enhances endosomal size and leads to an
increased number of intraluminal vesicles (ILVs) and in-
creased secretion of exosomes containing the APP-CTF.
TSPAN6 recruits the cytosolic adaptor syntenin through
its PDZ1 domain which explains the increased exosome
release, while the impaired degradation of proteins is
due in part to the decreased fusion between autophago-
somes and lysosomes caused by TSPAN6 expression.
Thus the accumulation of APP-CTF is caused by a dual
mechanism putting TSPAN6 in a pivotal point in the
pathway of ILV towards exosomes or lysosomal degrad-
ation. The cellular pathology resembles the wide spread
endolysosomal disturbances observed in neurons from
patients suffering from sporadic AD.
Methods
Western blots
Total cell lysates were prepared in lysis buffer containing
50 mM HEPES pH 7.4, 150 mM NaCl, 1% TritonX100
(unless otherwise indicated) and complete protease in-
hibitors (Roche Applied Science). Post-nuclear fractions
were taken, and protein concentrations were determined
using standard BCA assay (Pierce Biotechnology). Pro-
teins were separated on NuPAGE 4–12% Bis–Tris gels
(Invitrogen) and transferred to nitrocellulose membranes
for Western blot analysis. After blocking the membrane
with 1% non-fat milk in T-TBS 1× (0.05 M Tris, pH 7.5;
0.15 M NaCl; 0.1% Tween20), the proteins were detected
with the commercial antibodies: polyclonal anti-TSPAN6
antibody (1/500; Abgent), monoclonal MAB5232 anti-CTF-PS1 and monoclonal MAB1563 anti-NTF-PS1 (1/
5000; Chemicon/Millipore), monoclonal 9C3 anti-Nct
(1/5000), monoclonal 6E10 anti-Aβ (SIGNET), mono-
clonal anti-LC3β (D11) XP (1/1000; Cell Signalling),
polyclonal anti-sAPPβ (1/1000; Covance), monoclonal
anti-BACE1 D10E5 (1/1000; Cell Signalling), polyclonal
anti-p62 (1/1000), monoclonal anti-FlagM2 antibody
(1/4000; Sigma-Aldrich), monoclonal anti-βactin (1/
5000; Sigma), polyclonal anti-APLP2 (1/1000; W2CT
donated by Dominic Walsh), monoclonal anti-LRP1
EPR3724 (1/15000; Epitomics), monoclonal anti-Tsg101
(1/1000; Santa Cruz). The following in-house made
antibodies: B63 for APP (1/10,000), B80 for Aph1a (1/
1000) and B126 for Pen2 (1/2000).
Signals were detected using the chemiluminescence
detection with Renaissance (PerkinElmer Life Sciences).
Quantifications were performed by densitometry with
the software AIDA
Generation of the Tspan6 knockout mice and genotyping
For this KO line, ES cells derived from the 129/OlaHsd
mouse substrain were used to generate chimeric mice.
F1 mice were generated by breeding with C57BL/6
females. F2 homozygous mutant mice were produced
by intercrossing F1 heterozygous males and females.
The KO line has subsequently been backcrossed several
times to C57BL/6.
In order to genotype the Tspan6 KO mice, tails were
lyzed with KAPA Genotyping Kit (KAPA Biosystems)
following the instructions of the company. For the PCR,
3 different primers were used: 5’- TGTGATCAAGG
ACTCAAGCTTGTAC-3’, 5’-CTTACTCACCAGTTTCA
GCATCCAG-3’ and 5’-GGGTGGGATTAGATAAATG
CCTGCTCT -3’.
Immunohistochemistry on brain sections
Immunohistochemistry was performed as described in
[32]. Briefly, antigen retrieval was performed in citrate
buffer (0.018 M citric acid.H2O, 0.082 M sodium citrate,
pH = 6) using microwave heating. Endogenous peroxi-
dases and non-specific antigens were blocked by incu-
bating sections in 0.3% H2O2 for 20 min followed by a
1:5 diluted normal horse serum block for 30 min. Sec-
tions were incubated overnight at 4 °C with primary
antibodies: polyclonal anti-Tspan6 C-terminus (Abgent,
1:50 dilution), mouse monoclonal (mAb) anti-vGlut2
(Abcam, 1:2000 dilution) and mAb anti-GAD67 (Milli-
pore, 1:500 dilution). Sections were further incubated
with biotin conjugated secondary antibodies and extra-
vidin conjugated HRP, each for 30 min at room
temperature, and detected with 5, 5’ diaminobenzidine
(Dako, Heverlee, Belgium). Images were captured using
40x objective and Olympus UC30 colour camera
(Olympus, Antwerp, Belgium).
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tions of anti-Tspan6 C-terminus antibody (Abgent, 1:50
dilution) with either anti-vGlut2 mouse monoclonal
(Abcam, 1:2000 dilution) or anti-GAD67 mouse mono-
clonal (Millipore, 1:500 dilution) were incubated over-
night and detected with DAG-Cy3 and DAM-Cy5
(Jackson Immunoresearch). Sections were counter-
stained with 5 μg/mL DAPI (Sigma-Aldrich, Diegem,
Belgium) for 5 min and visualized with a dual spinning
disk confocal microscope (UltraView VoX, PerkinElmer,
Seer green, UK) and images analysed using Volocity
(PerkinElmer) essentially as described earlier [32].
Mouse brain homogenates for western blot
Pieces of cerebral cortices of 1 year old Tspan6+/Y
(n = 7) and Tspan6-/Y (n = 7) mice or 1 year old
AppNL/F x Tspan6 wt (n = 5) and AppNL/F x Tspan6 KO
mice (n = 6) were homogenized on ice in 0.5 M sucrose
PKM buffer (100 mM Potassium phosphate; 5 mM
MgCl2; 3 mM KCl; pH 6.5) containing 1% TritonX100
and 0.1% SDS. After removal of the debris by 30 minuts
centrifugation at 14.000 rpm and 4 °C, 40 μg of total pro-
tein per sample was loaded on NuPAGE 4-12% Bis-Tris
gels (Invitrogen).
Mouse brain homogenates for ELISA
Pieces of mice cerebral cortices coming from 1 year old
Tspan6+/Y (n = 7) and Tspan6-/Y (n = 7) mice were
weighted and homogenized in 5 volumes of pre-filtered
extraction buffer (0.4% diethanolamine, 50 mM NaCl, 1x
Protease inhibitors (Roche)) with Fastprep (45 s at 6 m/
s). The homogenates were centrifuged at 14.000 rpm for
5 min at 4 °C and the supernatants were ultracentrifuged
at 90.000 rpm for 30 min at 4 °C. A 10% volume of
neutralization buffer (0.5 M Tris-HCl, pH = 6.8) was
added to the new supernatants before determination of
the Aβ40 and Aβ42 content by ELISA. For normalization
purposes, protein concentration was measured by stand-
ard BCA assay (Pierce Biotechnology).
Primary neurons
Primary cultures of mouse cortical neurons were ob-
tained from Tspan6 KO mice at E14.5. The procedure
was carried out in accordance with the Ethic Com-
mittee of K. Leuven University (Ethische Commissie
Dierproeven, KULeuven). Briefly, the cortical region
of the brain was aseptically dissected and trypsinized
for 15 min. Cells were seeded in phenol‐red MEM
with L-glutamine (Invitrogen) plus 10% horse serum
and 0.6% glucose into 0.1 mg/ml poly‐l‐lysine coated
plates. After 120 min, medium was removed and neu-
robasal medium containing B27 supplement (NB-B27)
was added.ELISA
For detection of human and mouse Aβ, an in-house
ELISA sandwich was carried out. Briefly, 96-wells Nunc-
Immuno plates (Nunc, Denmark) were coated overnight
at 4 °C with JRF AB038 antibody for Aβ1‐38, JRF cAb040/
28 antibody for Aβ40 or JRF Ab042/26 antibody for Aß42
(Janssen Pharmaceutica), all used at 1.5 mg/ml in PBS
containing 0.1% casein (Casein Buffer). Plates were
washed 5 times with Washing Buffer (PBS-0.05% Tween
20) before the addition of the samples or the standard
curve made with consecutive dilutions (from 100 to
0.0003 ng/ml) of human or mouse Aβ40 and Aβ42 (rPep-
tide). Detection antibody was obtained from Janssen;
huAB25‐HRPO. After overnight incubation at 4 °C and 5
time washes with the Washing Buffer, the samples were
developed with a 0.02% TMB (tetramethylbenzidine) solu-
tion in Sodium Acetate (100 mM pH 4.9) containing
0.03% H2O2. The reaction was stopped with 0.2 N H2SO4
and read at 450 nm on a Perkin Elmer Envision 2103 mul-
tilabel reader.
Immunoisolation of late compartments
Late compartments were isolated from HEK293 cells co-
expressing an empty vector or myc-TSPAN6 together
with LAMP1 fused to mRFP and to a double Flag-tag
(LAMP1-mRFP-Flag) as previously described in Zoncu
et al. [33] with small variations. Briefly, cells were har-
vested from 2 x T175 flasks per condition through scrap-
ing in cold PBS, spun down and resuspended in 1 ml of
fractionation buffer: 50 mM KCl, 90 mM K-Gluconate,
1 mM EGTA, 5 mM MgCl2, 50 mM Sucrose, 20 mM
HEPES, pH 7.4, supplemented with 2.5 mM ATP, 5 mM
Glucose and protease inhibitors. Cells were mechanically
broken by passing them through a 23G needle attached to
a 1 ml syringe, then spun down at 2000 g for 10 min,
yielding a post nuclear supernatant (PNS). The PNS was
brought to 2 ml with fractionation buffer and subjected to
immunoprecipitation with 50 μl of anti-FlagM2 affinity
beads for 3 h at 4 °C. Late-compartments were in this way
captured by the beads while the rest of organelles were
washed out by 3 consecutive washes with fractionation
buffer. Late-compartments bound to the beads were re-
suspended in loading buffer and proteins were separated
on a 4-12% SDS-PAGE gel. After transferring proteins
onto a nitrocellulose membrane by western blot, the en-
richment of late compartments were analyzed with an
anti-LAMP1 antibody, the content of APP and APP-CTF
was evaluated with a polyclonal anti-APP antibody (B63)
and the overexpression of TSPAN6 was determined by a
polyclonal TSPAN6 antibody.
Pulse-chase
HEK293 cells were seeded on 6-well plates and co-
transfected with FlagAPP-C99 and an empty vector or
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labeled with radioactive methionine/cysteine [35S] for
15 min. Cells were chased for indicated time points and
lyzed in lysis buffer (1% TritonX100 in 100 mM NaCl,
50 mM HEPES pH 7.2 and protease inhibitors). FlagAPP-
C99 was immunoprecipitated from the cell lysates using
FlagM2-Sepharose beads (Sigma-Aldrich) and submitted
to SDS-PAGE/western blot. Radiolabeled proteins were
visualized with phosphoimaging.
Proximity ligation assay (PLA)
PLA was carried out with the DuoLink In Situ Kit accord-
ing to the manufacturer guidelines (Olink Bioscience).
Briefly, HEK293 cells transfected with myc-TSPAN6 or
left untransfected (technical control) were fixed in 4%
paraformaldehyde on coverslips and blocked with block-
ing solution (0.3% TritonX100 and 5% goat serum in PBS)
for 15 min at RT. A mouse monoclonal anti-myc antibody
(9E10) and a rabbit monoclonal anti-APP antibody (Y188)
were diluted 1/200 in PBS and applied to the samples for
2 h at RT in a humidity chamber. After removing the pri-
mary antibodies by 3 consecutive washes with PBS (5 min
each), the samples were incubated for 1 h at 37 °C with
the PLA Probes diluted 1/5 in PBS. After the incubation
time, the unbound PLA probes were removed by consecu-
tive washes with Buffer A (provided by the manufacturer),
followed by the incubation of the samples for 30 min at
37 °C with the ligase. Buffer A was used to wash the sam-
ples before the addition of the polymerase-amplification
solution. After 100 min incubation at 37 °C in a humidity
chamber, the samples were washed with buffer B (pro-
vided by the manufacturer) and mounted for analysis by
confocal microscopy.
γ-Secretase assay with endogenous substrate
HEK293-APPwt cells were transfected with myc-TSPAN6,
and 24 h post-transfection cell membranes were prepared.
Cells were harvested and resuspended in hypotonic buffer
(10 mM Tris, pH 7.3, 10 mM MgCl2, 1 mM EDTA and
1 mM EGTA) for 10 min on ice. Cells were then homoge-
nized by passing 15 times through a 21G needle and cen-
trifuged for 10 min at 100 g to pellet nuclei. The resulting
supernatant was centrifuged 30 min at 16 000 g. Pelleted
membranes were resuspended in citrate buffer (150 mM
sodium citrate, adjust pH 6.4 with citric acid, complete
protease inhibitors) and incubated at 4 °C (as negative
control) or at 37 °C for 2 h. Analysis of γ-secretase
products was performed with standard SDS-PAGE/
western blot.
γ-Secretase assay with exogenous substrate
HEK293 cells were transfected with myc-TSPAN6 for
24 h or treated with siRNA-TSPAN6 for 48 h. Cell were
homogenized in Buffer A (20 mM pipes pH7, 140 mMKCl, 0.25 M sucrose, 5 mM EGTA) with complete prote-
ase inhibitors (Roche Applied Science) and the microsomal
membrane fraction was obtained by ultracentrifugation at
55.000 rpm at 4 °C. Cell-free assays were performed as
described by Kakuda and colleagues [34] with some minor
modifications. Briefly, microsomal membrane fractions
solubilized in Buffer B (50 mM pipes, pH7, 0.25 M sucrose,
1 mM EGTA) containing 1% CHAPSO were mixed with
recombinant APP-C99-3 × FLAG substrate (0.5 μM final
concentration), 0.0125% phosphatidylethanolamine, 0.1%
phosphatidylcholine, and 2.5% DMSO. Reactions were
incubated at 37 °C for 4 h. Aβ species produced during the
reaction were measured by ELISA and the levels of
AICD produced were determined by SDS-PAGE elec-
trophoresis and western blot with a mouse anti-
FlagM2 and goat anti-mouse IR800 antibody. Infrared
signals were detected using the Odyssey Infrared Im-
aging System.
Exosomes isolation and quantification
HEK293 cells non-overexpressing (control) or overex-
pressing TSPAN6 were incubated for 2 days under grow-
ing conditions (at 37 °C and 5% CO2) with Exosomes-
depleted medium obtained by overnight ultracentrifuga-
tion of 20% FBS-supplemented DMEM/F12 at 100.000 g
and 4 °C and diluted 1:2 in FBS-free DMEM/F12. After
2 days the medium was collected and the death cells and
other debris were removed by consecutive centrifuga-
tions at 4 °C at 200 g for 10 min, 2000 g for 10 min and
12000 g for 45 min. Finally the exosomes were obtained
by ultracentrifugation of the supernatant at 110.000 g
for 1 h at 4 °C. The pellet containing the exosomal
fraction was washed once with pre-filtered PBS and
posterior ultracentrifugation at 110.000 g for 1 h at
4 °C. The quality of the exosomal fraction obtained by
this method was determined by comparing the pro-
tein expression of exosomal markers and non-
exosomal proteins between total lysate and the exoso-
mal fraction after electrophoretic separation of the
samples on 4-12% SDS-PAGE and posterior western
blot analysis with specific antibodies against the ER
marker calnexin, Tsg101, TSPAN6 and actin. Deter-
mination of the number of exosomes present in the
exosomal fraction was carried out by Nanosight.
Electron microscopy
HEK cells and primary neurons grown on aclar cover-
slips were rinsed briefly and fixed in 1.3% glutaraldehyde
in 66 mM cacodylate buffer for 2 h at RT before pro-
cessing for electron microscopy. Then the cells were
washed for 30 min in 0.1 M cacodylate buffer and post-
fixed for 2 h at RT in 1% OsO4, 1.5% K4Fe(CN)6 in
0.1 M cacodylate buffer. Cells were rinsed again in
0.1 M cacodylate buffer and stained with 3% uranyl
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transferring the cells to 35%, 50%, 70%, 90% and two
steps of 100% ethanol for 10 min each. The cells were
then embedded in EMbed812 and resin blocks were
sectioned on an ultramicrotome (Leica Ultracut UCT,
Leica Mycrosystems). Ultrathin sections (70 nm) were
mounted on copper grids and imaged using a JEM-1400
transmission electron microscope (JEOL), equipped
with an 11Mpixel Olympus SIS Quemesa camera.
Quantifications of the area and number of subcellular
compartments were performed with the image process-
ing software ImageJ (Fiji distribution).
Lentiviral vectors production and transduction of
neurons in culture
The vectors psPAX2 and pMD2.G were constructed and
provided by D. Trono (Geneva, Switzerland); the vector
pLVx-puro was used to subclone Tspan6.
Lentiviral particles were produced by using TransIT-
LT1 transfection protocol on 60% confluent HEK293.
Cells were transfected with a plasmid mix containing
the vector pLVx encoding Tspan6 (LV-Tspan6) or
empty pLVx (LV-cnt), the packaging construct psPAX2
and the envelope plasmid pMD2G-VSVG (at the fol-
lowing ratio 1.5:2:1). After 4 h post-transfection, the
medium was replaced by fresh growth medium and
cells were left for 24 h to produce viral particles. The
24 h-medium was harvested and fresh growth medium
was added to the cells for additional viral production.
After another 24 h the medium was harvested and
mixed with the first 24 h medium. The medium was
ultracentrifugated at 50.000 g for 2 h at 16 °C to pellet
down the viral particles. Finally, the lentiviral vesicles
were resuspended in sterile 100 μL PBS.
Primary cortical neurons derived from Tspan6+/Y and
Tspan6-/Y E14.5 embryos were plated in 12-wells plates
and transduced at DIV 6 by replacing the growth
medium (NB-B27) by fresh neurobasal medium without
B27 (NB) containing 3 μL of LV-TSPAN6 or LV-cnt.
After 4 h the medium was replaced by the original NB-
B27 and the neurons were left for 2 days to express the
gene of interest. At DIV 9 the medium was replaced by
experimental medium (NB containing only glutamate)
and 24 h later it was collected for Aβ determination
and neurons were lyzed in lysis buffer for western blot
analysis or fixed in 1.3% glutaraldehyde in 66 mM caco-
dylate buffer for EM analysis.
Confocal laser scanning microscopy and quantification
Cells were plated on glass coverslips, transfected 24 h
and processed for indirect immunolabeling the next day
as in [35]. Images were captured on a confocal micro-
scope (Leica TCS SP5 II, Leica Microsystems) connected
to an upright microscope, using an oil-immersion planApo 60x A/1.40 NA objective lens. Image acquisition
was performed with LAS (Leica Microsystems Gmbh,
Wetzlar, Gemany) and further processed with ImageJ
(Rasband, W.S., ImageJ, U. S. National Institutes of
Health, Bethesda, Maryland, USA, http://imagej.nih.
gov/ij/, 1997–2016). The ImageJ plugin JACoP (Fabrice
P. Cordelieres, Institut Curie, Orsay, France. Susanne
Bolte, IFR 83, Paris, France) was used for signal coloca-
lization by overlap quantification (Manders coefficients).
Images were acquired with identical settings and regions
of interest covering whole cells were used for quantifica-
tion [36]. Data are expressed as mean ± s.e.m. from n cells
Study of autophagic flux
HEK293 cells were seeded on 12-well plates and trans-
fected with an empty vector or TSPAN6. After 24 h the
cells were washed once with Earle's Balanced Salt Solu-
tion (EBSS) medium and incubated with EBSS medium
for the time indicated with or without 10 μM Bafilomy-
cine A1. After the incubation time, the cells were lyzed
in lysis buffer at 4 °C and proteins were analyzed by
SDS-PAGE electrophoresis and western blot. The acti-
vation of autophagy was analyzed with a polyclonal
antibody anti-LC3β (Cell Signalling) and a polyclonal
antibody against p62. The effect of the activation of
autophagy on the degradation of APP-CTF or PS1-CTF
(negative control) was evaluated with a polyclonal anti-
body against APP (B63) and a monoclonal antibody
against PS1-CTF (Millipore). The overexpression of
TSPAN6 was evaluated with a polyclonal antibody
against TSPAN6 (Abgent).
Cell-based assay for Notch
HEK293 cells were seeded on 6-wells plates (800.000
cells/well). For the evaluation of the effect of TSPAN6
overexpression on the γ-secretase-mediated cleavage
of Notch, cells were co-transfected with NotchΔE and
an empty vector or TSPAN6. For the study of the ef-
fect of TSPAN6 downregulation on Notch processing,
cells were co-transfected with siRNA against TSPAN6
(siRNA-TSPAN6) or a scrambled siRNA (siRNA-cnt)
and NotchΔE. The cells were treated with 10 μM lacta-
cystine overnight to allow the accumulation of the NICD
product before lyzing the cells in lysis buffer for 20 min.
After lysis, the samples were spun down for 14.000 rpm
for 15 min at 4 °C and 30 μg of total protein of the
supernatant was run on a 12% MES gel and transferred
to a nitrocellulose membrane by western blot. Analysis
of NotchΔE cleavage was evaluated with a monoclonal
antibody against cleaved Notch1 (Val1744; 1/1000) and a
monoclonal antibody against myc (9E10; 1/15000). Goat
anti-mouse IR700 antibody and goat anti-rabbit IR800
antibody were used to analyze the infrared signals of the
bands with the Odyssey Infrared Imaging System.
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Total RNA was extracted from HEK293 cells expressing
an empty vector or TSPAN6 with the miRVana kit
(Thermo Fisher Scientific). Briefly, cells were collected
in 1 ml ice-cold Trizol after a brief wash in ice-cold PBS
and homogenized with a 23G syringe needle on ice.
After the addition of 200 μL chloroform the homogenate
was centrifuged at 12,000 g for 1 min at RT and the
aqueous phase (~400 μL) was transferred to a new tube
and mixed with 1.25 volumes of ethanol 100% at RT.
The mixture was loaded onto a column and spun at
12,000xg for 40 s at RT. After several washes of the col-
umn with washing solutions, total RNA was eluted with
RNA-free water (50 ng/μL). To obtain the cDNA, the
reverse transcription mix contained 4 μl of total RNA
(200 ng), 4 μl of 5× reaction buffer, 2 μl of enzyme mix
and 10 μl of water. The reactions were incubated at 42 °C
for 1 h followed by inactivation at 95 °C for 5 min.
For real-time PCR determination of the APP and
BACE1 mRNA levels, samples were diluted 40x and 5 μl
product was assessed in a PCR reaction mix containing
10 μl of SYBR Green master mix. Real‐time PCR was
performed on 96‐wells plates using the LightCycler 480
Real‐Time PCR system (Roche, Indianapolis, IN, USA).
The PCR conditions were 95 °C, 10 min followed by
45 cycles at 95 °C, 10 s and 55 °C, 20 s. The crossing
point (Cp) was determined by using the second deriva-
tive method and data were normalized with actin. Fold
changes and statistical significance were calculated using
one‐way ANOVA.
NMR spectroscopy and C-terminal peptide ligand titration
For the heteronuclear magnetic resonance spectroscopy
(NMR) analysis of syntenin-1 and TSPAN6 interaction,
uniformly 15 N-labeled syntenin-1 PDZ tandem domain
(113 to 273), referred to as “syntenin-1 PDZ12,” was
expressed as a GST fusion in Escherichia coli BL21
(DE3) at 25 °C in M9 minimal medium using 15NH4Cl
as the sole nitrogen source. The purification of GST-
fused protein was performed as reported previously [37].
The NMR samples contained 200 μM protein, 150 mM
NaCl, 500 μM TCEP [Tris(2-carboxyethyl)phosphine],
and 50 μM AEBSF in 50 mM Tris buffer (pH 7.5). All
NMR spectra were recorded at 30 °C on a Varian
Inova 800-MHz spectrometer equipped with a room
temperature 5-mm 1H/13C/15 N z-axis pulse field
gradient probe, with data processed using the Azara
package and analyzed using Ansig [38]. Synthesized C-
terminal TSPAN6 peptide was purchased from Sigma-
Genosys and contained an extra Arg residue at the N
terminus, to improve peptide solubility. Titrations of
syntenin-1 PDZ12 proteins with C-terminal TSPAN6
peptide were conducted by recording a series of 1H,15N
HSQC spectra of 15 N-labeled protein (200 μM), withincreasing molar concentrations of the peptide ligand,
up to a protein-to-peptide ratio of 1:8. The combined
backbone 1H and 15 N chemical shift changes, Δδ, were
calculated as reported earlier [39].
Syntenin contructs
Constructs expressing syntenin wt and mutants were
obtained as described previously [40].
Brain clearing and 3D Lightsheet imaging
The AppNL-F/NL-F mice were generated before [41]. Fixed
brains from 1 year old AppNL/F x Tspan6 KO and
AppNL/F x Tspan6 Wt mice were permeabilized with 1%
Triton X-100 at room temperature for 24 h. Amyloid
plaques were stained in 0.1% Thioflavin-S solution for
24 h. Then we rinsed them 2 times in PBS and dehy-
drated the tissue in an ethanol series (30%, 50%, 70%,
80%, 96% and 2 times in 100%, 1 day incubation time
each) at room temperature. We rinsed the brains in
100% hexane for 1 h and then transferred them into a
clearing solution of 1 part Benzyl Alcohol (Sigma) in 2
parts Benzyl Benzoate (Sigma), aka BABB. We stored
whole brains in the clearing solution for at least 2 days
at room temperature before imaging.
After clearing of intact mouse brains, imaging was
achieved using a custom made Lightsheet microscope.
The detection unit is equipped with a Nikon Macro-
scope AZ100M (Nikon Europe, The Netherlands), an
ORCA R2 camera (Hamamatsu, Japan) and single band-
pass and longpass filters (SemRock, Rochester, NY). The
magnification used to resolve amyloid plaques was in a
range of 9x-12x and cortical volumes of about Illumin-
ation was achieved with a 50 mm focal length cylindrical
lens providing a lightsheet thickness in the order of 5–
10 microns, with a slitted and collimated beam of
488 nm and 561 nm solid state lasers.
Image analysis of 3D volume
A custom ImageJ macro was used to extract, count and
measure the individual volumes of the amyloid plaques
in the acquired image Z-stacks. The macro performs the
detection of candidate plaques (hits) by extracting 3D
objects around significant intensity maxima. It then dis-
plays local volumes (boxes) cropped around hit loca-
tions, both in Thiaflovin and control (autofluorescence)
channels, into an image montage. The user can navigate
to hit locations within the full volume by interacting
with the montage and discards invalid hits based on vis-
ual inspection. Intensity Z-projections of the cropped
volumes is also displayed to quickly guide the user to
suspicious hits. Validated amyloid plaques are finally
automatically counted and their individual volumes
exported to coma separated text files for further statis-
tical analysis.
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TSPAN6 alters cellular proteostasis
Given that several studies [29–31] show that TSPAN6
transcripts increase in late Braak stages of the Alzhei-
mer’s disease brain, we first overexpressed a myc-tagged
form of TSPAN6 (myc-TSPAN6) in human embryonic
kidney (HEK293) cells. As we anticipated that tetraspa-
nins affect γ-secretase activities, we selected APP and
two other known substrates of γ-secretases, i.e. APLP2
and LRP1 for further analysis. Levels of APP, APLP2 and
LRP1 full length proteins were not affected upon
TSPAN6 overexpression in HEK cells stably expressing
APP (HEK-APPwt) (Fig. 1a). However a strong accumu-
lation of their respective CTFs (APP-CTF, APLP2-CTF
and LRP1-CTF; Fig. 1a,b) was seen. Aβ40 but not Aβ42
was increased in the conditioned medium of TSPAN6
transfected cells (Fig. 1c), suggesting a preserved γ-
secretase activity. The increased levels of substrateFig. 1 TSPAN6 affects the normal proteostasis of the cell. a TSPAN6 was t
western blot using antibodies against APP, APLP2 and LRP1. The CTF leve
elevated by overexpressing TSPAN6. No changes in the levels of full-leng
were observed. b Quantification of bands in panel a confirmed the incre
ELISA in the 24 h conditioned medium of HEK-APPwt cells like those in p
of HEK-APPwt cells treated 48 h with a scrambled siRNA (siRNA-cnt) or a
as in panel a (n = 3 experiments). In contrast to panel a, the levels of APP
TSPAN6-treated cells. e Quantification of bands in panel d. f Aβ levels det
panel d show a significant decrease in Aβ40 levels. g HEK293 cells were c
and lysates analyzed by western blot with antibodies against FlagM2 and
panel g. i Aβ in the 24 h conditioned medium of the cells from panel g
levels. j Transfected HEK293 analyzed by pulse-chase labeling. Cells were
immunoprecipitated at specific time-points with FlagM2-affinity gel. The
plotted (n = 3 experiments). This shows a slower disappearance of FlagAP
HEK293 cells co-transfected with myc-tagged NotchΔE and TSPAN6 or an
change myc-NΔE levels. l Quantification of panel k shows no differences
determined by t-test (*p <0.05, **p <0.01, ***p <0.001)(APP-CTF) might explain the increased Aβ40 but some
effects on the processivity of the enzyme cannot be ex-
cluded given the selective effect on Aβ40. γ-Secretase ex-
pression was not affected by TSPAN6 overexpression
Additional file 1: Figure S1a) and no effects were seen
in vitro in γ-secretase activity assays using microsomal
fractions of control, TSPAN6-overexpressing or TSPAN6-
downregulated HEK-APPwt cells (Additional file 2: Figure
S2a,b). Interestingly, the expression levels of BACE1 and
the consequent generation of sAPPβ in early endosomes
(EE) [35] were elevated by TSPAN6 while no changes in
the levels of ADAM10 and sAPPα were found (Additional
file 1: Figure S1a-c). In contrast, downregulation of en-
dogenous TSPAN6 in HEK-APPwt cells using siRNA gave
the opposite results: reduced CTF levels of APP, APLP2,
LRP1 (Fig. 1d,e) and reduced BACE1- and sAPPβ-levels
(Additional file 1: Figure S1d-f), with no change in the
levels of the γ-secretase components.ransfected in HEK-APPwt (n = 3 technical repeats) and analyzed by
ls of APP (APP-CTF), APLP2 (APLP2-CTF) and LRP1 (LRP1-CTF) were
th proteins for APP (APP-FL), APLP2 (APLP2-FL) and LRP1 (LRP1-FL)
ase in CTF levels of APP, APLP2 and LRP1. c Aβ determination by
anel a shows increased Aβ40 levels (n = 3 experiments). d Cell lysates
siRNA against TSPAN6 (siRNA-TSPAN6) were analyzed by western blot
-CTF, APLP2-CTF and LRP1-CTF were strongly reduced in siRNA-
ermined by ELISA in the 24 h-conditioned medium of the cells in
o-transfected with FlagAPP-C99 and TSPAN6 or an empty vector
6E10 (n = 3 experiments). h Quantification of FlagAPP-C99 from
measured by ELISA. TSPAN6 overexpression increases Aβ40 and Aβ42
incubated for two hours with 35S-Met/Cys and FlagAPP-C99 was
density of the bands in the autoradiography was quantified and
P-C99 during the first 30 min in cells overexpressing TSPAN6. k
empty vector (n = 3 experiments). TSPAN6 overexpression do not
in terms of NICD production in TSPAN6. Statistical significance was
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tered proteolysis we focused on the accumulation of
the APP-CTFs which are generated by α- or β-
secretases (APP-C83 and APP-C99, respectively). We
co-transfected HEK293 cells with similar amounts of
Flag-tagged APP-C99 (FlagAPP-C99) and an empty
vector (negative control) or TSPAN6 (Fig. 1 g). Both
FlagAPP-C99 and secreted Aβ levels were enhanced by
TSPAN6 (Fig. 1 g-i), consistent with the altered prote-
olysis of the APP-CTF fragments. We also tested the ef-
fect of TSPAN6 on myc-tagged Notch-ΔE, a synthetic
fragment from Notch that is used as a direct substrate
for γ-secretase, and which can be compared to APP-
CTF. The Notch-CTF did not change and generation of
the Notch intracellular domain (NICD) by γ-secretase
was not affected following overexpression or down
regulation of TSPAN6 (Fig. 1 k,l; Additional file 2:
Figure S2c,d), indicating specificity of the TSPAN6-
mediated effect on APP-CTF, APLP1-CTF and LRP1-
CTF relative to the Notch-CTF.
The turn-over of FlagAPP-C99 was further investigated
with pulse-chase experiments. Cells were radiolabeled
with 35S-Met/Cys. At the time points indicated, FlagAPP-
C99 was immunoprecipitated and analyzed by SDS-PAGE
and autoradiography. TSPAN6-overexpression resulted in
a delay in the degradation of FlagAPP-C99 which was
overcome after 30 min (Fig. 1j). The endogenous protein
can accumulate in presence of high TSPAN6 levels assum-
ing that APP-C99 is continuously being produced and
considering the delayed start of its degradation. Altogether
these data strongly suggest that TSPAN6 affects specific-
ally the degradation of some proteins, including APP-CTF,
APLP2-CTF and LRP-CTF.
APP-CTFs accumulate in endosomal compartments in
TSPAN6-overexpressing cells
We next investigated the subcellular compartmentalization
and accumulation of APP-CTF upon TSPAN6 overexpres-
sion. As shown in Fig. 2, TSPAN6 is mainly present in
LAMP1 positive organelles and to a lesser extent in EEA1
positive organelles. By contrast, we found no-colocalization
with the Golgi marker GM130. APP-CTFs show strong co-
localization with TSPAN6 in LAMP1 cellular compart-
ments (Fig. 3a,b). This co-localization was specific for the
CTFs of APP since N-terminal epitopes of APP show only
a weak co-localization with myc-TSPAN6 (Additional file
3: Figure S3). Remarkably, overexpression of myc-TSPAN6
increases the co-localization of endogenously expressed
APP-CTF with LAMP1 by threefold and with EEA1 by
twofold (Fig. 3a,b). We confirmed the enrichment of APP-
CTFs in LAMP1 positive organelles by immunoisolation
of these compartments after expression of Flag-tagged
LAMP1 (Flag-LAMP1) and using Flag-tag antibody
coupled to beads [33]. APP-CTF was found to enrich inthe immunoprecipitated LAMP1 positive organelles when
cells overexpressed TSPAN6 (Fig. 3c), confirming that
TSPAN6 increases the levels of APP-CTFs in these
compartments.
TSPAN6 favors the generation of exosomes
These studies indicate that TSPAN6 impairs degradation
of the APP-CTF that accumulates in endosomal com-
partments. Thus we decided to study these organelles at
the ultrastructural level on HEK293 cells overexpressing
TSPAN6 by Transmission electron microscopy (EM).
EM analysis revealed that expression of TSPAN6 led to
a duplication of the number of endosomal structures.
These were moreover 40% larger than those observed in
control cells (Fig. 4a-c). Furthermore, in TSPAN6-
expressing cells intraluminal vesicles (ILVs) of multivesi-
cular bodies (MVBs) were somewhat larger when com-
pared to control cells (Fig. 4 ac-af ). These data were
further confirmed by stereological analysis that demon-
strated that the ILVs present in cells overexpressing
TSPAN6 have a larger surface compared to the largest
ILVs found in control cells and also appear to display
more empty space in EM (Fig. 4d).
APP-CTF degradation can occur via sorting into ILVs
from the rim of the MVB followed by fusion to lysosomal
or autolysosomal compartments. Given the altered ILVs
morphology found by EM analysis, we explored a possible
defect in this pathway as a TSPAN6-induced mechanism
leading to APP-CTF accumulation. We expressed the con-
stitutively active GTP-locked mutant form of the early
endosomal marker Rab5 (Rab5Q79L). Rab5Q79L blocks re-
cycling from EEs resulting in enlarged EEs through fusion
events without affecting the formation of ILVs [42]. As
shown in Fig. 5, TSPAN6 co-localizes with Rab5Q79L at
the rim of such enlarged endosomes but is also found in
the lumen (Fig. 5a). Interestingly APP-CTF distribution
between the rim and the lumen of MVBs was not different
between TSPAN6-overexpressing and control cells
(Fig. 5a,b), indicating that TSPAN6 does not interfere with
the sorting of APP-CTF into ILVs (Fig. 5b). The enlarging
effect of Rab5Q79L on endosomes is however significantly
enhanced in the presence of TSPAN6 (Fig. 5c).
Ubiquitinated proteins are recognized by ESCRT-
proteins and sorted to ILVs in MVB. Further degradation
occurs when the latter fuse to autophagosomes and
lysosomes. Alternatively cargo sorted to tetraspanin-
enriched microdomains in the limiting membrane of the
endosome may go to ILVs destined for exosome release
in an ESCRT-independent manner [43]. APP-CTF accu-
mulates in TSPAN6-enriched microdomains, as demon-
strated by sucrose gradient fractionation of CHAPSO-
solubilized lysates from TSPAN6-overexpressing cells
(Additional file 4: Figure S4a) and a proximity ligation
assay of APP-CTF and myc-TSPAN6 (Additional file 4:
Fig. 2 Subcellular localization of TSPAN6 in HEK293 cells. HEK293 cells were transfected with myc-tagged TSPAN6 (myc-TSPAN6), fixed and immu-
nostained for EEA1 as an early-endosomes marker (upper panels), LAMP1 and CD63 as markers for late-compartments (middle panels), and
GM130 to visualize the Golgi organelle (lower panels). Myc-TSPAN6 (detected with a rat monoclonal anti-myc antibody) shows a high de-
gree of co-localization (arrows) with late-compartments (detected with a mouse monoclonal antibody against LAMP1 and a rabbit polyclonal anti-
body against CD63), and a lower co-localization with early endosomes (detected with a mouse monoclonal antibody against EEA1). Low
co-localization was observed with the Golgi organelle (detected with a monoclonal antibody against GM130). Scale bars = 10 μm
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show larger ILVs (Fig. 4a-d), resembling those generated
by the ESCRT-independent pathway [44]. We therefore
compared the number of exosomes secreted from
TSPAN6-overexpressing HEK293 cells and from control
cells (Fig. 5d-g). We used the particle tracking system
Nanosight to count and to determine the size of the vesi-
cles present in the conditioned medium. TSPAN6 overex-
pression increased the average (μ) number of exosomes(μvector = 1280 × 10
6; μTspan6 = 2139 × 10
6; Fig. 5, f,g),
which shows an average size of about 120 nm (Fig. 5 g).
Both TSPAN6 and APP-CTF were present in exosomes
isolated from HEK293 cells (Fig. 5e). Thus, TSPAN6
significantly affects the generation of exosomes, and al-
though the amount of APP-CTF per exosome remains
equal (Fig. 5e), the total pool of APP-CTF in exosomes is
thus increased by 60%, partially explaining the APP-CTF
accumulation in TSPAN6 overexpressing cells.
Fig. 3 APP-CTF accumulates in endosomal compartments in TSPAN6-overexpressing cells. a Immunofluorescence microscopy of HEK293 cells
overexpressing myc-tagged TSPAN6, fixed and probed with a rat monoclonal antibody against myc, a rabbit monoclonal antibody against APP-
CTF (Y188), and mouse monoclonal antibodies against EEA1 and LAMP1 to visualize early and late endosomal compartments, respectively. Cells
overexpressing myc-TSPAN6 show more APP co-localizing with EEA1 and LAMP1 (filled arrowheads) compared to non-overexpressing cells
(empty arrowheads). b Quantification of the number of cells non-overexpressing or overexpressing TSPAN6 showing co-localization of APP-CTF
with early (EEA1) or late endosomal (LAMP1) compartments. c Immunoisolation of LAMP1-containing compartments as described [33], after
overexpressing Flag-tagged LAMP1 in non-overexpressing or overexpressing myc-tagged TSPAN6. The total inputs and the immunoisolated
compartments were analyzed by western blot with specific antibodies against APP, APP-CTF, TSPAN6 and LAMP1. Statistical significance was
determined by t-test (***p <0.001)
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and mediates the increased formation of ILVs fated for
exosome secretion
The syndecan-syntenin-alix pathway triggers the biogen-
esis of ILVs destined to be secreted as exosomes, by-
passing the degradative pathway [45]. These effects resem-
ble those observed here in TSPAN6-overexpressing cells.
In addition, syntenin interacts with the carboxy-terminal
end of tetraspanin CD63 [39]. Thus we investigated if syn-
tenin mediates the TSPAN6-induced generation of ILVs
destined to exosomes and whether it might be involved in
the decreased APP-CTF degradation.
Syntenin is an adapter protein that consists of an N-
terminal domain, followed by a tandem PDZ module
and a C-terminal domain. The PDZ module recognizes
short sequences at the C-terminus of transmembrane
proteins [46]. We investigated if the C-terminus of
TSPAN6 contains a canonical PDZ-binding motif thatcan interact to syntenin. We therefore generated a
series of mutants at the C-terminus of myc-tagged
TSPAN6 (Fig. 6a) substituting each time a single amino
acid residue for glycine. While Flag-tagged syntenin co-
immunoprecipitates myc-TSPAN6, the substitution of
one of the last two C-terminal amino acids by glycine
disrupted this interaction (Fig. 6a,b). In addition we
found that the immobilized C-terminal peptide of
TSPAN6 and CD63 (positive control) but not the corre-
sponding regions of some other tetraspanins (i.e.,
CD81, Net-5, Net-2 and CD231) can retain syntenin
from cell lysates (Fig. 6c), confirming the specificity of
this interaction.
To further demonstrate the interaction between
TSPAN6 and syntenin in vitro, we co-transfected
HEK293 cells with Flag-TSPAN6 and HA-tagged wt
syntenin (SYNwt-HA) or HA-tagged syntenin lacking
the first 101 N-terminal (SYNΔN-HA) or the last 17
Fig. 4 Endosomal alterations in TSPAN6-overexpressing cells. a EM images showing enlarged compartments in HEK293 cells overexpressing
TSPAN6. HEK293 cells expressing an empty vector (control) present endosomes (aa) showing a normal aspect and multivesicular bodies
(MVBs; ac and ae) containing normal-sized intraluminal vesicles (ILVs, empty arrowheads). In comparison, HEK293 cells overexpressing TSPAN6
show a higher number of endosomal compartments (ab), some of them with non-degraded material in the lumen (ab, arrowheads) and MVBs
with enlarged ILVs (ad and af; arrowheads). The nucleus is indicated with an N. b Quantification of the number of endosomes from TEM
images of HEK293 cells like those shown in panel a. Overexpression of TSPAN6 increases the number of endosomal compartments per cell
(n = 72 control cells; n = 59 TSPAN6-transfected cells; 2 independent experiments). c Analysis of the size of endosomal compartments from
TEM images. Larger endosomal compartments are found in HEK293 cells overexpressing TSPAN6 in comparison to controls cells expressing an
empty vector (n = 167 endosomes for control cells; n = 267 for TSPAN6-transfected cells; 2 independent experiments). d Determination of the
surface of ILVs from TEM images like those shown in panel a. All the ILVs from the control or the TSPAN6-overexpressing cells were grouped
according to their size in μm2 (n = 202 ILVs from control cells; n = 204 ILVs from TSPAN6-overexpressing cells; 2 independent experiments).
This demonstrates enrichment for larger structures in the TSPAN6 overexpressing cells. The mean of the surface plotted for each range
shows larger ILVs in cells overexpressing TSPAN6 when comparing ILVs larger than 0.1 μm2. Statistical significance was determined by t- test
(*p <0.05, ***p <0.001)
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immunoprecipitated SYNwt-HA and SYNΔN-HA but
not SYNΔC-HA, suggesting that, like CD63, the C-
terminus of syntenin is necessary for the stabilization
of the interaction with TSPAN6 (Fig. 7a). In order to
investigate the role played by the PDZ1 and PDZ2
domains of syntenin in the interaction, we performed
NMR titration analysis of 15N-labeled syntenin PDZ1&2
with unlabeled C-terminal peptide of TSPAN6 consist-
ing of the last 10 amino acids of the human protein
(TSPAN6-C). The chemical shift perturbations were
used to map the binding sites, revealing a contact sur-
face for TSPAN6-C predominantly in the PDZ1 domain
binding pocket (Fig. 7b).In order to evaluate the relevance of the TSPAN6-
syntenin interaction for exosome production, we com-
pared the number of these vesicles secreted by HEK293
cells after stable knock down of syntenin (HEK-Syn KD)
and transfected with an empty vector or with a vector
expressing TSPAN6 (Fig. 7c). The total number of exo-
somes generated by HEK-Syn KD is dramatically lower
compared to the wild type HEK293 cells, in agreement
with the role that syntenin, together with syndecan and
alix, plays in the biogenesis of exosomes [45]. Interest-
ingly, in HEK-Syn KD cells, and as opposed to HEK293
wt cells (Fig. 5f,g), overexpression of TSPAN6 did not
increase the total number of exosomes (compare Fig. 5f,g
with Fig. 7c), nor the size distribution (Fig. 7d). This
Fig. 5 TSPAN6 is found in ILVs and enhances the formation of exosomes. a Representative staining of 2 independent experiments showing
HEK293 cells overexpressing the Rab5Q79L mutant together with an empty vector (upper panels) or myc-TSPAN6 (lower panels). Immunofluorescence
studies were carried out with monoclonal antibodies against myc (to detect TSPAN6), APP-CTF and Rab5. APP-CTF is observed in the lumen
(filled arrowheads) and the limiting membrane (empty arrowheads) of endosomes in both conditions; however, cells overexpressing myc-
TSPAN6 show enlarged endosomes. Scale bar = 10 μm. b Percentage of APP-CTF in the lumen or the rim of endosomes in cells overexpressing
an empty vector (n = 109 endosomes; 2 independent experiments) or myc-TSPAN6 (n = 106 endosomes; 2 independent experiments). c
The average area (pixels2) of Rab5Q79L endosomes in cells overexpressing myc-TSPAN6 (n = 75 endosomes; 2 independent experiments)
was increased in comparison to control cells expressing an empty vector (n = 65 endosomes; 2 independent experiments). d Western
blot analysis of total HEK293 lysates (transfected with Flag-TSPAN6 or left untransfected) or the exosomal fraction (Exo) isolated from their
conditioned medium. The blot was probed with a monoclonal antibody against FlagM2 and a polyclonal antibody against TSPAN6 to
assess the overexpression of protein, a monoclonal antibody against calnexin (non-exosomal protein), a polyclonal antibody against Tsg101
(exosomal protein) and a monoclonal antibody against actin. e The western blot of total HEK293 lysates and their exosomal fractions shows
no differences in the APP-CTF levels for the same amount (2.5 μg) of exosome lysates when TSPAN6 is overexpressed. f Quantification of the
concentration of secreted exosomes (vesicles/ml) by the nanovesicles tracking system Nanosight from control HEK293 cells or overexpressing
TSPAN6 (3 independent experiments per condition), shows that TSPAN6 increases the secretion of exosomes. g Graph showing the distribution
of the concentrations of the vesicles grouped by size (nm) and found in the exosomal fractions of TSPAN6-overexpressing HEK293 cells and
control cells (data from panel f). TSPAN6-overexpressing cells show a higher concentration for all the vesicle sizes. Statistical significance was
determined by t-test (**p <0.01)
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necessary in the formation of ILVs destined to exosomes.
We next investigated whether TSPAN6-triggered accu-
mulation of APP-CTF occurs in HEK-Syn KD cells. The
western blot analysis shows that TSPAN6 can induce the
same APP-CTF accumulation in both wt and KD cells
(Fig. 7e,f ), suggesting that syntenin is largely dispensable
for the effect. This conclusion was supported by the ob-
servation that the same amount of APP-CTF accumu-
lated in HEK293 after co-expressing TSPAN6 together
with syntenin wt (Syn-wt) or a syntenin mutant which is
unable to interact with TSPAN6 (Syn-PDZ1*) (Fig. 7
g,h). The results thus suggest that TSPAN6 stabilizes
APP-CTF by an additional mechanism upstream of
syntenin-induced exosome formation.TSPAN6 overexpression impairs the fusion of
autophagosomes to lysosomes
TSPAN6 induces the accumulation of enlarged endosomal
compartments (Fig. 4a-c) suggesting an impairment of the
downstream degradative pathways. In addition we found
that autophagosomal and multilamellar compartments,
(Fig. 8aa-ad) together with enlarged endosomes filled with
heterogeneous material (Fig. 8ab-ac) are more commonly
found in HEK293 cells overexpressing TSPAN6.
Hence we investigated whether TSPAN6 overexpression
affects the degradation of APP-CTF by impairing the
autolysosomal pathway. Firstly, we determined how the
autophagic flux affects APP-CTF degradation in non-
transfected (control) or TSPAN6-transfected HEK293
cells (Fig. 8b-d). Autophagy was induced by starvation of
Fig. 6 The C-terminal cytoplasmic region mediates the interaction of
TSPAN6 with syntenin-1. a Table illustrating the location of the point
mutations on the myc-tagged TSPAN6 mutants used in the co-
immunoprecipitation experiment shown in b. b Co-expression of
Flag-tagged syntenin in HEK293 cells together with myc-tagged
TSPAN6-wt or lacking one of the last c-terminal amino acids (TSPAN6(-1)
to TSPAN6(-7)). After immunoprecipitation of Flag-tagged syntenin,
the interaction with the different TSPAN6 mutants was evaluated by
western blot with an anti-myc antibody. The last 2 amino acids of
TSPAN6 are essential for the interaction with syntenin. c N-terminally
biotinylated peptides corresponding to the indicated C-termini of
tetraspanins were synthesized and conjugated to avidin-agarose
beads. HEK293 cells ectopically expressing HA-tagged syntenin were
lysed in immunoprecipitation buffer (0.5% Brij 98-0.5% Triton X-100-PBS),
incubated with the avidin-immobilized peptides and the interaction
to syntenin was analyzed by western blot. TSPAN6 (Tsp6) and CD63
(positive control) C-terminal peptides also interacted with syntenin.
Net-5, Net 2 (negative controls reported not to interact to syntenin),
CD231 or CD81 did not interact to syntenin
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(EBSS) medium for 2 h and 4 h, as previously reported
[47–49]. The lysosome inhibitor bafilomycin A1 was
added to the medium of 4 h starved cells as a positive con-
trol to estimate maximal APP-CTF accumulation. In con-
trol cells, APP-CTF levels decreased by about 40% after
4 h of starvation while the levels remained unchanged in
TSPAN6-overexpressing cells (Fig. 8b,c). The levels of
p62, a protein involved in the recognition of ubiquitinated
proteins by the autophagosome, were also less decreased
during autophagy induction in TSPAN6-overexpressing
cells (Fig. 8b-d), though the impairment on p62 degrad-
ation was not so pronounced as for APP-CTF.In order to test the hypothesis that TSPAN6 impairs the
fusion between autophagosomes and lysosomes, HEK293
cells were co-transfected with the autophagosome-
associated protein LC3 double-tagged with GFP and RFP
(LC3-GFP-RFP) and an empty vector or myc-TSPAN6.
Cells were put into starvation with EBBS medium for 3 h
to induce the formation of autophagosomes (Fig. 8e). The
fusion of newly formed autophagosomes with lysosomes is
reflected in loss of green fluorescence of the GFP protein
due to the low pH of lysosomes. Cells overexpressing
myc-TSPAN6 (blue) showed a decreased ratio of the num-
ber of red vesicles versus the total number of vesicles (red
and green) per cell (Fig. 8f). This, together with the paral-
lel increased number of autophagosomes in cells overex-
pressing myc-TSPAN6 (Fig. 8 g), suggests a decreased
fusion of autophagosomes to lysosomes. Cells kept in
normal growth medium in similar circumstances did not
display autophagosomes (Additional file 5: Figure S5).
APP processing is altered in neurons of Tspan6 KO mice
In order to evaluate whether TSPAN6 exerts similar ef-
fects on the amyloidogenic pathway in a physiologically
relevant context we investigated the effect of a loss of
function mutation on APP processing in the cerebral
cortex of adult Tspan6 wt or Tspan6 KO mice. As shown
in Fig. 9a, Tspan6 is expressed in neuronal bodies of the
cerebral cortex of Tspan6 wt mice but not in Tspan6 KO
mice. We observed a moderate to intense Tspan6 re-
activity in brain regions with neurons expressing glutam-
ate decarboxylase (GAD)-67, an enzyme involved in
GABA synthesis, and in neurons expressing the vesicular
glutamate transporter 1 (vGLUT1), a glutamate trans-
porter that transports cytoplasmic glutamate into vesi-
cles (Additional file 6: Figure S6). We then compared
the expression levels of App and Bace1 in the cerebral
cortex of 1 year old Tspan6 wt and Tspan6 KO mice by
western blot (Fig. 9b). App expression levels were signifi-
cantly decreased in Tspan6 KO mice, while App-CTF
and Bace1 showed minimal effects (Fig. 9b,c). Tspan6
KO mice show also lower levels of Aβ40 and Aβ42 pep-
tides in the cerebral cortex (Fig. 9d). We also cultured
primary cortical neurons from Tspan6 wt, het, or KO
E14.5 embryos. The expression levels of App-CTFs were
decreased in Tspan6 het and Tspan6 KO neurons com-
pared to Tspan6 wt neurons (Fig. 9e,f ). The protein
levels of App, App-CTFs, Bace1, and the secretion of
sAppβ were decreased in Tspan6 KO neurons (Fig. 9e, f ).
Tspan6 KO neurons produced less Aβ40 compared to
Tspan6 wt neurons (Fig. 9 g), while Aβ42 was only minim-
ally affected. Finally overexpression of Tspan6 in Tspan6
wt and KO neurons increased the protein levels of App
and p62, indicating a deficit in autophagy, and the
secretion of Aβ40 and Aβ42 to the media (Additional
file 7: Figure S7a,b). However no effects on App-CTF
Fig. 7 The interaction of syntenin with TSPAN6 mediates the enhanced formation of exosomes. a Flag-tagged TSPAN6 (Flag-TSPAN6) and HA-tagged
syntenin (SynWt-HA) or syntenin lacking either the N-terminal fragment (SynΔN-HA) or the C-terminal fragment (SynΔC-HA) were co-transfected in
HEK293 cells. Flag-TSPAN6 was immunoprecipitated with an anti-Flag antibody from cell lysates and the interaction was evaluated by western blot
using an anti-HA antibody. Total lysates (first 3 lanes) show that the 3 syntenin constructs were expressed. However only SynWt-HA and SynΔN-HA
but not SynΔC-HA were immunoprecipitated with Flag-TSPAN6. The absence of anti-Flag antibody gives no bands (negative control, last 3 lanes). b
Nuclear magnetic resonance spectroscopy (NMR) analysis of syntenin-1 and TSPAN6 interaction. The left panel shows the superposition of six two-
dimensional 1H-15 N-HSQC spectra of uniformly 15 N-labeled syntenin-1 PDZ domain (200 μM) titrated with increasing concentrations of C-terminal
peptide of TSPAN6. The right panel shows the locations of syntenin PDZ residues involved in binding. c Exosomes isolated from the conditioned
medium of HEK293 cells stably knocked down for syntenin (HEK-Syn KD) and overexpressing an empty vector (control) or TSPAN6 were analyzed by
Nanosight. Overall, the number of exosomes is lower in HEK-Syn KD cells compared to HEK293 wt cells (Fig. 5f). Overexpression of TSPAN6 in HEK-Syn
KD did not alter the number of exosomes secreted. d Same plot as in Fig. 5 g but for HEK293 cells stably knocked down for syntenin (HEK293-KD
Syntenin). Neither number of exosomes nor size distribution change between TSPAN6-overexpressing and control cells (data from panel c). e HEK293
or HEK-Syn KD were co-transfected with an empty vector (control) or with TSPAN6 (n = 3 technical replicates). TSPAN6 overexpression increases the
APP-CTF levels in both HEK293 and HEK-Syn KD cells. f Quantification of the western blots of panel e. g HEK293 cells were transfected with an empty
vector (control), TSPAN6 alone or with either syntenin (Syn) or syntenin with a point mutation in PDZ1 domain (PDZ1) that prevents the interaction to
TSPAN6. Lysates were analyzed by western blot (n = 3 technical replicates). Overexpression of TSPAN6 increases the APP-CTF levels. This effect
is potentiated by co-expression of Syn or PDZ1 mutant. h Quantification of APP-CTF levels from the western blot shown in panel g. Statistical
analysis was carried out with t-test (** p <0.01 vs vector; ## p0.01;vs TSPAN6 alone)
Guix et al. Molecular Neurodegeneration  (2017) 12:25 Page 14 of 21and Bace1 levels were observed. The impairment of au-
tophagy was confirmed by EM analysis of Tspan6 wt
neurons overexpressing Tspan6, which show enlarged
vesicles with undegraded material in the lumen (Fig. 10),
resembling those found in TSPAN6-overexpressing HEK
cells. These data demonstrate that Tspan6 is physiologic-
ally involved in neural APP metabolism.
Finally, we investigated the consequences of Tspan6
loss in an AD mouse model by crossing Tspan6 KO mice
with mice expressing endogenous levels of the human
APP gene with the Swedish and Iberian mutations
(AppNL/F) that trigger the formation of amyloid plaques
[41]. When we examined by western blot total lysates of
the cerebral cortex of 1 year old AppNL/F x Tspan6 KO,
we observe a decrease in the levels of App-CTF, Bace1,
Aβ and p62 in comparison to AppNL/F x Tspan6 wt
mice. However we did not find differences in terms ofamyloid plaque content by using a combination of a
brain clearing methodology with Thioflavin-S staining
(Additional file 8: Figure S8c).
Discussion
We demonstrate here that TSPAN6 is localized in
endosomal and lysosomal structures and plays a critical
role in the complex housekeeping of MVBs in the cell.
Overexpression of TSPAN6 dramatically altered the
morphology of these structures, causing alterations in
the turnover of several proteins including APP-CTF,
BACE1 and Aβ involved in AD. The increased secretion
of Aβ peptide seems to be a direct consequence of the
increment in the levels of APP-CTF due to TSPAN6
overexpression, as supported by the parallel increase in
the levels of secreted Aβ and transfected FlagAPP-C99
in cells overexpressing TSPAN6. This was corroborated
Fig. 8 Overexpression of TSPAN6 compromises autophagy. a HEK293 cells overexpressing TSPAN6 analyzed by TEM show phagosomes (aa)
multilamellar bodies (ad) and large vacuoles containing undegraded heterogeneous material in the lumen (ab-ac, arrowheads). In comparison,
HEK293 cells expressing an empty vector present a reduced number of enlarged vesicles with homogeneous luminal material (ae-af, empty
arrowheads). Nucleus is indicated with an N. b Representative experiment showing autophagy induction in control (empty vector) or TSPAN6-
overexpressing HEK293 cells by 2 h and 4 h starvation. Lysates were analyzed by western blot with antibodies against TSPAN6, APP, P62, LC3β, PS1-CTF
and actin. TSPAN6-overexpressing cells show no degradation of APP-CTF after 4 h starvation compared to control cells. Activation of autophagy was
assessed by conversion of LC3-I into LC3-II and the degradation of P62. The levels of PS1-CTF and actin were used as negative controls. c Quantification
of APP-CTF levels from western blots like in panel b (n = 3 experiments). d Quantification of P62 levels from western blots like in panel b (n = 3
experiments). e HEK293 cells co-transfected with LC3-GFP-RFP and an empty vector or myc-TSPAN6 were starved for 3 h to induce autophagy. The fusion
of autophagosomes (red and green) with lysosomes (red) is reflected in the loss of the fluorescence of GFP protein due to the low pH found in lysosomes.
TSPAN6 overexpression is detected with an anti-myc antibody (blue) (scale bar = 10 μm). f Ratio between the number of autophagosomes fused to
lysosomes versus the total number of autophagosomes (2 independent experiment; n = 43 autophagosomes for control; n = 43 autophagosomes for
TSPAN6). g The number of phagosomes not fused to lysosomes (red and green) per cell is increased in cells overexpressing TSPAN6 (2 independent
experiments, n = 59 cells for control; n = 80 cells for TSPAN6). h Scheme showing the cellular pathways affected by TSPAN6. 1-Increased levels of
TSPAN6 increment the secretion of exosomes by a syntenin-dependent mechanism. 2-TSPAN6 impairs the fusion between autophagosomes and
lysosomes affecting the cellular proteostasis. Statistical significance was determined by t- test (*p <0.05, **p <0.01, ***p <0.001), Ɨ p <0.05)
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accumulation of transduced FlagAPP-C99 is observed
(Additional file 9: Figure S9). On the other hand we could
not demonstrate APP-CTF accumulation at endogeneous
levels of APP expression in neurons, in contrast to HEK
cells. Apparently, as we see still increased Aβ secretion in
TSPAN6 overexpressing neurons, the neurons have add-
itional capacity to turn-over APP-CTF. (Additional file 7:
Figure S7b).It is clear that the effects of TSPAN6 on APP-CTF and
Aβ generation are complex. Apart from a decreased
turn-over (which makes more APP-CTF available for γ-
secretase cleavage), and an increased secretion of APP-
CTF containing exosomes, there is also an increase of
BACE1 levels by TSPAN6 in HEK 293 cells. While this also
might contribute to the increased generation of secreted
Aβ, the fact that APP-CTFs are stabilized when overex-
pressed, indicates a BACE-1 independent mechanism.
Fig. 9 TSPAN6 controls neural protein homeostasis in vivo. a Immunohistochemistry on cerebral sections of the cortex (layer 4) of Tspan6 Y/+ and
Tspan6 Y/- adult mice (1 year old, scale bar = 40 μm). Sections were probed with a polyclonal anti-Tspan6 antibody. Only neuronal bodies of Tspan6 Y/+
were positive. b Western blot analysis of the cerebral cortex of Tspan6 Y/+ and Tspan6 Y/- adult mice (7 x Tspan6 Y/+ and 7 x Tspan6 Y/- 1 year old mice).
c Quantification of bands shown in panel b shows a statistically significant decrease of the App levels in Tspan6 Y/- mice and slightly decreased levels
of App-CTF and Bace1 that do not reach statistical significance. d ELISA determinations of the Aβ content in the cerebral cortex of the mice in panel b.
Aβ40 levels were significantly decreased in Tspan6 Y/- mice. e Western blot analysis of lysates of Tspan6 wt (Tspan6 +/+ or Tspan6 Y/+), Tspan6 het
(Tspan6 +/-) and Tspan6 KO (Tspan6 -/- or Tspan6 Y/-) E15 primary neuronal cultures showing a reduction in the protein levels of App, App-CTF, sAppβ
and Bace1 in Tspan6 het and KO cultures. f Quantification of the intensity of the bands of western blot experiments as in panel e show a statistically
significant reduction in the protein levels of App, App-CTF, sAppβ and Bace1 in Tspan6 KO primary neuronal cultures (n = 8 for wt, n = 8 for
het, n = 8 for KO). g Aβ levels measured by ELISA in 24 h conditioned medium show a statistical significant reduction of Aβ40 levels in Tspan 6
KO neurons (n = 8 for wt, n = 3 for het, and n = 4 for KO). Statistical significance was determined by t-test (*p <0.05, **p <0.01)
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degradation and increasing exosome release, suggests
that TSPAN6 affects the lysosomal-MVB-exosome sys-
tem at the level of ILVs destined either for degradation
or biogenesis of exosomes. The sorting of proteins to
ILVs is a crucial step in the proper degradation of pro-
teins (including APP) as MVBs fuse to lysosomes but
also determines the secretion of proteins via exo-
somes. At least two molecular signals have been
involved in determining the type of ILVs generated:
the ESCRT-dependent pathway drives the degradation
of the cargo via lysosomes/autophagosomes while
ESCRT-independent pathways, such as ceramide-rich
membrane microdomains or tetraspanins, are thought
to generate ILVs destined to exosomes. Our results
show that overexpression of TSPAN6 in HEK293 cells
induces enlarged endosomes with ILVs morphologic-
ally resembling those of ESCRT-depleted cells. In
addition this is accompanied by an increased secretionof exosomes which depends on the specific interaction
of TSPAN6 with syntenin. Syntenin allows syndecans
and associated molecules to escape degradation by fa-
cilitating their translocation to the exosomal route
[45]. Thus, our data suggest that TSPAN6 induces an
ESCRT-independent formation of ILVs destined for the
biogenesis of exosomes in disfavor of an ESCRT-
dependent pathway destined to degradation, which ex-
plains the stabilization of APP-CTF. Although TSPAN6
interaction with syntenin is required for the increased
formation of exosomes, we found that TSPAN6 over-
expression increased APP-CTF levels even in the ab-
sence of syntenin. These results suggest that TSPAN6
exerts an additional proteostatic effect on APP-CTF.
However, it is interesting to notice that in low syntenin
conditions, TSPAN6-triggered APP-CTF accumulation
is less pronounced, suggesting that syntenin is respon-
sible for at least part of the effect observed. In turn,
the PDZ mutant of syntenin can per se induce the
Fig. 10 6 DIV primary cortical neurons derived from Tspan6 wt (Tspan6+/Y) E14.5 embryos were infected with an empty lentiviral vector (LV-cnt)
or a lentiviral vector overexpressing Tspan6 (LV-Tspan6). At 9 DIV neurons were washed and processed for EM analysis. Tspan6 wt neurons that
overexpressed Tspan6 (e-h) show alterations by EM consisting of accumulation of electron dense material inside large vesicles (arrow) in the
soma compared to control neurons (a-d)
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existence of a TSPAN6-independent role of syntenin in
stabilizing APP-CTF.
The enhancement of ESCRT-independent mechanisms
impairs autophagy by affecting the fusion between
autophagosomes and lysosomes, as illustrated by the ac-
cumulation of autophagosomes in ESCRT-depleted cells.
Interestingly, TSPAN6 appears in a recently published
list of newly identified modulators of autophagy [28].
Here, we find decreased fusion between autophagosomes
and lysosomes in cells overexpressing TSPAN6, accom-
panied by the accumulation of the autophagic marker
p62 in HEK293 cells. The impairment of autophagy pro-
vides a mechanistic explanation for the accumulation ofAPP-CTF in cells overexpressing TSPAN6. In agreement
with a pivotal role for TSPAN6 at this critical junction, a
reduction in the levels of TSPAN6 triggers the opposite
effect of overexpression: a decrease in the levels of APP-
CTF in HEK cells and in neurons. However, further
work is needed to support an impairment of the ESCRT-
pathway by TSPAN6.
Interestingly, alterations in the endolysosomal–au-
tophagic system are well-recognized early pathological
features of AD, which is marked by prominent enlarge-
ment of endosomal compartments and progressive ac-
cumulation of autophagic vacuoles [50]. In addition,
neuronal deficiency of presenilin 1, whose mutations
trigger the dominant form of the disease [51], causes
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while conditional knockout mice for presenilin 1 accu-
mulate autophagosomes in the brain [54], indicating a
link between abnormal processing of presenilin sub-
strates and abnormalities in those pathways. By co-
expressing the Rab5Q79L mutant with TSPAN6 in
HEK293 cells, we observe exacerbated enlarged Rab5-
positive vesicles similar to those seen in neurons gener-
ated from induced pluripotent stem cells from AD
patients and Down syndrome fibroblasts [55, 56]. Ele-
vated levels of the APP-βCTF fragment generated by
BACE1 are sufficient to trigger the accumulation of
swollen endosomes by recruiting APPL1 [57]. Since
BACE1 protein levels and the APP-βCTF fragment are
increased in TSPAN6-overexpressing cells, it is plaus-
ible that the formation and accumulation of enlarged
endosomes are the consequence of APP-βCTF accumu-
lation. Further work should address to what extent the
accumulating APP-CTF may contribute to some of
these alterations. Further work is also needed to explain
the effects of TSPAN6 on the processivity of γ-
secretase processing reflected in increased Aβ40. As the
effect is not observed in cell free γ-secretase assays, it is
likely indirect and possibly caused by redistribution of
APP-CTF processing over different subcellular com-
partments or even different γ-secretase complexes [58]
after TSPAN6 overexpression, however, this needs fur-
ther investigation. On the other hand, the fact that the
decreased expression levels of soluble Aβ and proteins
involved in the amyloidogenic pathway observed in
AppNL/F x Tspan6 KO mice do not translate into a
lower number of plaques in these animals, suggests that
Tspan6 may be involved in other biological processes
controlling Aβ accumulation in the brain such as glial-
dependent Aβ uptake or clearance of the peptide from
the brain through the blood brain barrier. Further stud-
ies should clarify these other potential roles.
Conclusions
In conclusion, our study identifies TSPAN6, a moder-
ately up-regulated gene in the prefrontal cortex of AD
patients, as a new modulator of APP-CTF proteostasis
preventing its degradation by the impairment of the
autolysosomal pathway, leading to consequent enhanced
Aβ production, and turning the balance towards the for-
mation of ILVs destined to form exosomes (Fig. 8 h). Hu-
man neurodegenerative diseases including Alzheimer's
(AD), Huntington's, and Parkinson's diseases are associ-
ated with aberrant protein aggregation [59, 60], and loss
of proteostatic mechanisms are likely very central in
these diseases. Altogether, our work describes here the
biological role of TSPAN6 in the MVB pathway and re-
inforces the idea that altered proteostasis in neurons
may contribute to sporadic AD.Additional files
Additional file 1: Figure S1. a TSPAN6 was transfected in HEK293 cells
stably expressing human wtAPP (HEK-APPwt; 3 independent experiments
per condition) and analyzed by western blot using antibodies against
ADAM10, BACE1 and components of the γ-secretase complex. BACE1
levels were increased while γ-secretase components are not affected. A
representative actin blot of the samples (run on a separate gel) is shown.
b The activity of α- and β-secretase was determined by measuring the
sAPPα and sAPPβ levels by western blot, respectively, in the 24 h-condi-
tioned medium of the HEK293-APPwt cells from panel a. c The quantifica-
tion of the intensity of the bands in panel a and b shows that BACE1 and
sAPPβ levels are enhanced by TSPAN6 overexpression (n = 3 per condi-
tion) without any observable effect on sAPPα. d Same samples used in
Fig. 1d were analyzed by western blot as in panel a. Briefly, HEK-APPwt
cells were treated with a scrambled siRNA (siRNA-cnt) or a siRNA against
TSPAN6 (siRNA-TSPAN6). A polyclonal TSPAN6 antibody was used to cor-
roborate the decrease of TSPAN6 in siRNA-TSPAN6 treated cells. BACE1
levels were strongly reduced in siRNA-TSPAN6-treated cells. A representa-
tive actin blot of the samples (run on a separate gel) is shown. e sAPPα
and sAPPβ levels present in the 24 h-conditioned medium of cells of
panel d were determined by western blot. f Quantification of the inten-
sity of the bands in panel d and e shows that BACE1 and sAPPβ levels
are decreased by TSPAN6 downregulation without any observable effect
on sAPPα. Statistical significance was determined by t test (*p <0.05, **p
<0.01, ***p <0.001). (PDF 92 kb)
Additional file 2: Figure S2. a Microsomal fractions from HEK293 cells
downregulating (siRNA-TSPAN6; siRNA-cnt used as control; n = 3 technical
repeats per condition) or overexpressing TSPAN6 (TSPAN6; empty vector
used as control; n = 3 technical repeats per condition) were prepared for
in vitro γ-secretase assay. The γ-secretase inhibitor DAPT (1 μM) was added
as a negative control of the reaction. Analysis by western blot of the in vitro
assays shows no effects on the production of AICD by downregulating or
overexpressing TSPAN6. b In vitro γ-secretase assays were carried out by add-
ing exogenous substrate (3xFlagAPP-C99) to microsomal fractions obtained
from HEK293 cells overexpressing TSPAN6 or an empty vector (control) and
analyzed by western blot. The γ-secretase inhibitor DAPT (1 μM) was added
as a negative control. AICD production (detected with a monoclonal anti-
Flag antibody) was not changed by overexpression of TSPAN6. The gener-
ation of different Aβ species during the in vitro reactions was determined by
ELISA. No statistical differences in the different Aβ species produced were
observed. c HEK293 cells treated with siRNA-TSPAN6 or siRNA-cnt were trans-
fected with the γ-secretase substrate myc-NΔE and analyzed by western blot
(3 independent experiments). The blot was probed with a monoclonal anti-
myc antibody to detect myc-NΔE, a monoclonal antibody against cleaved
Notch1 (Val1744), a polyclonal antibody against TSPAN6 and a monoclonal
antibody against actin. No effects on the myc-NΔE levels were observed
when TSPAN6 is downregulated. d Plot of the ratio calculated from the
bands in panel c between the γ-secretase-dependent generation of NICD
and its substrate myc-NΔE. Cells down regulating TSPAN6 do not change
the production of NICD. e Determination of APP mRNA levels of HEK293 cells
transfected with an empty vector (control) or TSPAN6 by qPCR. No signifi-
cant differences in the APP mRNA levels were observed between control or
TSPAN6-overexpressing cells (n = 3 technical repeats per condition). f Deter-
mination of BACE1 mRNA levels of HEK293 cells transfected with an empty
vector (control) or TSPAN6 by qPCR. No significant differences in the BACE1
mRNA levels were observed between control or TSPAN6-overexpressing cells
(n = 3 technical repeats per condition). (PDF 182 kb)
Additional file 3: Figure S3. HEK293 cells transfected with myc-tagged
TSPAN6 (myc-TSPAN6) were fixed and studied by immunofluorescence.
Myc-TSPAN6, APP-CTF and APP-NTF were detected with a rat monoclonal
antibody against myc, a rabbit monoclonal antibody against APP-CTF
and a mouse monoclonal antibody against APP-NTF, respectively. Only
APP-CTF shows a strong colocalization with myc-TSPAN6. Scale bar =
10 μM. (PDF 235 kb)
Additional file 4: Figure S4. a HEK293 cells were solubilized in 1%
CHAPSO and fractionated by continuous sucrose gradient centrifugation.
Fractions were collected and analyzed by western blot and probed with
antibodies against markers for detergent-resistant (caveolin) or detergent-
Guix et al. Molecular Neurodegeneration  (2017) 12:25 Page 19 of 21solubilized (calnexin) membranes, as well as APP, BACE1, γ-secretase com-
ponents and TSPAN6. In the transfected cells APP-CTF showed a strong
shift to the TSPAN6 positive fraction. The profile of the percentage of the
intensity of the bands per each fraction versus the total intensity of APP-
CTF and caveolin was plotted for control or TSPAN6-overexpressing cells.
b Representative experiment of a proximity ligation assay (PLA) between
APP-CTF and TSPAN6 on HEK293 cells transfected with an empty vector
(control) or myc-tagged TSPAN6. Rabbit monoclonal antibody against
APP-CTF (y188) and rat monoclonal antibody against myc were used as
primary antibodies. Positive red dots indicating interaction events be-
tween APP-CTF and TSPAN6 were visualized by confocal microscopy,
while cells expressing an empty vector were negative. (PDF 247 kb)
Additional file 5: Figure S5. Negative control of autophagosomes
formation. HEK293 cells co-transfected with LC3-GFP-RFP and myc-
tagged TSPAN6 (myc-TSPAN6) were left with culture medium containing
10% FBS. LC3-GFP-RFP was distributed over the cytosol in contrast to cells
submitted to starvation (see Fig. 8e). Scale bars = 10 μm. (PDF 91 kb)
Additional file 6: Figure S6. Tspan6 immunoreactivity was present both
in regions of high glutamatergic neuronal content (upper panels: GAD67,
dentate gyrus) and high GABAergic neuronal content (lower panel: vGlut1,
thalamic reticular nucleus). Scale bars = 18 μm. (PDF 119 kb)
Additional file 7: Figure S7. a Western blots of lysates of Tspan6 wt
(Tspan6 +/+ or Tspan6 Y/+) and Tspan6 KO (Tspan6 -/- or Tspan6 Y/-)
primary neuronal cultures from different E14.5 embryos transduced with
an empty lentiviral vector (LV-cnt) or a lentiviral vector overexpressing
Tspan6 (LV-Tspan6). Overexpression of Tspan6 increases the levels of App
and the autophagosomal marker p62, indicating a deficit in the
autophagic pathway, but not of App-CTF and Bace1. Ponceau staining
shows similar loading per well. b Increased levels of Aβ40 (upper panel)
and Aβ42 (lower panel) determined by ELISA in the 12 h conditioned
medium of Tspan6 wt (Tspan6 +/+ or Tspan6 Y/+) and Tspan6 KO (Tspan6
-/- or Tspan6 Y/-) primary cortical neurons transduced with LV-Tspan6 (n
= 12 different E14.5 embryos for wt, n = 9 different E14.5 embryos for KO)
compared to neurons transduced with LV-cnt (n = 13 different E14.5 em-
bryos for wt, n = 10 different E14.5 embryos for KO). Statistical significance
was determined by t test (*p <0.05, **p <0.01 and ***p <0.001 for com-
parison between LV-cnt and LV-Tspan6 conditions, *Ɨp <0.05 for compari-
son between Tspan6 wt and Tspan6 KO). (PDF 140 kb)
Additional file 8: Figure S8. a Western blot analysis of lysates from the
cerebral cortex of 12 months old AppNL/F x Tspan6 wt (n = 5) and AppNL/F
x Tspan6 KO (n = 6) mice. The membranes were blotted with antibodies
against sAppβ, App, Aβ peptide, Bace1, p62 and actin. b Plot showing
the quantification of the bands on the western blot of panel a. The levels
of App-CTF, Bace1, Aβ and p62 are decreased in AppNL/F x Tspan6 KO
mice (n = 6) compared to AppNL/F x Tspan6 wt mice (n = 5). c Thioflavin
staining of cleared brains was performed from 1 year old AppNL/F x
Tspan6 wt (n = 5) and AppNL/F x Tspan6 KO mice (n = 5) mice to visualize
and quantify the 3D content of amyloid plaques. No differences in the
number or the volume occupied by amyloid plaques was detected in
AppNL/F x Tspan6 KO mice versus AppNL/F x Tspan6 wt mice. Statistical sig-
nificance was determined by t-test (*p <0.05, **p <0.01). (PDF 168 kb)
Additional file 9: Figure S9. a 6 DIV Tspan6 wt (Tspan6 +/+ or Tspan6
Y/+), Tspan6 het (Tspan6 -/+) and Tspan6 KO (Tspan6 -/- or Tspan6 Y/-)
primary neuronal cultures were transduced with an adenoviral vector
expressing the human APP-C99 triple tagged with a Flag peptide (AV-
3xFlagAPP-C99) at a MOI of 100. After 48 h, 4 independent cultures of
each condition were lysed and analyzed by western blot using a mono-
clonal antibody against Flag in order to detect the FlagAPP-C99 expres-
sion; Actin is used as a loading control. b Quantification of bands shown
in panel a. Tspan6 KO neurons accumulate less FlagAPP-C99 after trans-
duction in comparison to Tspan6 wt neurons. Statistical significance was
determined by t-test (*p <0.05, ***p <0.001). (PDF 106 kb)Abbreviations
AD: Alzheimer’s disease; APP: Amyloid precursor protein; APP-CTF: APP-C-
terminal fragments; EBSS: Earle’s balanced salt solution; EE: Early endosomes;
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